Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients.

Thibault PasseriPierre-Olivier ChampagneAnne-Laure BernatShunya HanakitaHenri SalleEmmanuel MandonnetSébastien Froelich

Published in: Acta neurochirurgica (2019)

We report the first cases of meningiomas responsiveness to discontinuation of hormonal therapy with NOMAC. Similarly to cases associated with long-term CPA intake, tumor reduction, and improvement of clinical symptoms can be observed after cessation of NOMAC.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
stem cells
metabolic syndrome
bone marrow
mesenchymal stem cells
physical activity
patient reported
weight loss
replacement therapy
smoking cessation